1. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow.
- Author
-
Jakes C, Millán-Martín S, Carillo S, Scheffler K, Zaborowska I, and Bones J
- Subjects
- Animals, Antibodies, Monoclonal analysis, Batch Cell Culture Techniques methods, Biosimilar Pharmaceuticals analysis, Biosimilar Pharmaceuticals chemistry, CHO Cells, Cathepsin L analysis, Cathepsin L chemistry, Cathepsin L genetics, Cricetulus, Drug Contamination, Glycosylation, Immunoglobulin G analysis, Immunoglobulin G genetics, Lipoprotein Lipase analysis, Lipoprotein Lipase chemistry, Lipoprotein Lipase genetics, Lysine chemistry, Quality Control, Recombinant Proteins analysis, Recombinant Proteins chemistry, Recombinant Proteins genetics, Succinimides chemistry, Trypsin chemistry, Workflow, Antibodies, Monoclonal chemistry, Chromatography, Liquid methods, Mass Spectrometry methods
- Abstract
The multi-attribute method (MAM) is a liquid chromatography-mass spectrometry based method that is used to directly characterize and monitor many product quality attributes and impurities on biotherapeutics, most commonly at the peptide level. It utilizes high-resolution accurate mass spectral data which are analyzed in an automated fashion. MAM is a promising approach that is intended to replace or supplement several conventional assays with a single LC-MS analysis and can be implemented in a Current Good Manufacturing Practice environment. MAM provides accurate site-specific quantitation information on targeted attributes and the nontargeted new peak detection function allows to detect new peaks as impurities, modifications, or sequence variants when comparing to a reference sample. The high resolution MAM workflow was applied here for three independent case studies. First, to monitor the behavior of monoclonal antibody product quality attributes over the course of a 12-day cell culture experiment providing an insight into the behavior and dynamics of product attributes throughout the process. Second, the workflow was applied to test the purity and identity of a product through analysis of samples spiked with host cell proteins. Third, through the comparison of a drug product and a biosimilar with known sequence variants. The three case studies presented here, clearly demonstrate the robustness and accuracy of the MAM workflow that implies suitability for deployment in the regulated environment.
- Published
- 2021
- Full Text
- View/download PDF